胰高血糖素样肽-1受体
Glucagon-like peptide-1 receptor.
作者信息
Krashes Michael
机构信息
Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Curr Biol. 2024 Dec 2;34(23):R1163-R1164. doi: 10.1016/j.cub.2024.10.039.
PMID:39626623
Abstract
Michael Krashes discusses glucagon-like peptide-1 receptors, their physiological role in glucose metabolism and the mode of action of their agonists that are used to treat obesity and were later shown to promote weight loss.
摘要
迈克尔·克拉希斯讨论了胰高血糖素样肽-1受体、它们在葡萄糖代谢中的生理作用以及用于治疗肥胖症且后来被证明能促进体重减轻的激动剂的作用方式。
Zotero 插件